Chemistry:MVT-602

From HandWiki
Short description: Chemical compound
MVT-602
MVT-602 TAK-448.svg
Clinical data
Other namesRVT-602; TAK-448
Identifiers
CAS Number
PubChem CID
IUPHAR/BPS
DrugBank
UNII
ChEMBL
Chemical and physical data
FormulaC58H80N16O14
Molar mass1225.376 g·mol−1
3D model (JSmol)

MVT-602 (other developmental code names RVT-602, TAK-448) is a kisspeptin receptor agonist which is under development for the treatment of female infertility and hypogonadism.[1][2] It has been found to increase luteinizing hormone levels in premenopausal women.[2] As of March 2021, MVT-602 is in phase 2 clinical trials for the treatment of female infertility and hypogonadism.[1] It was also under development for the treatment of prostate cancer, but development for this indication was discontinued.[1]

References

  1. 1.0 1.1 1.2 "MVT 602". Adis Insight. Springer Nature Switzerland AG. https://adisinsight.springer.com/drugs/800029425. 
  2. 2.0 2.1 "Kisspeptin receptor agonist has therapeutic potential for female reproductive disorders". The Journal of Clinical Investigation 130 (12): 6739–6753. December 2020. doi:10.1172/JCI139681. PMID 33196464. 

External links